UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002603 |
|---|---|
| Receipt number | R000003176 |
| Scientific Title | Phase I study of Gemtuzumab Ozogamicin given in combination with Enocitabine and Daunorubicin as induction therapy for elderly patients with acute myeloid leukemia |
| Date of disclosure of the study information | 2009/10/13 |
| Last modified on | 2011/10/12 11:54:33 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/10/08 16:47:33 | ||
| 2 | Update | 2011/10/12 11:54:33 | Recruitment status Date of closure to data entry |
